Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria A. Palomero"'
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel García-Saenz, Maria del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez-Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution of
Externí odkaz:
https://doaj.org/article/6320cb09619d46bdb0b5fd843bc4c5e3
Autor:
Valeria Reynolds-Cortez, Maria Haro, Maria Carralero-Palomero, Mar Gomez-Santillana, Edgar Silva-Contreras
Publikováno v:
Population Medicine. 5
Autor:
Haifeng Tang, Kristian Jensen, Evelyne Houang, Fiona M. McRobb, Sathesh Bhat, Mats Svensson, Art Bochevarov, Tyler Day, Markus K. Dahlgren, Jeffery A. Bell, Leah Frye, Robert J. Skene, James H. Lewis, James D. Osborne, Jason P. Tierney, James A. Gordon, Maria A. Palomero, Caroline Gallati, Robert S. L. Chapman, Daniel R. Jones, Kim L. Hirst, Mark Sephton, Alka Chauhan, Andrew Sharpe, Piero Tardia, Elsa A. Dechaux, Andrea Taylor, Ross D. Waddell, Andrea Valentine, Holden B. Janssens, Omar Aziz, Dawn E. Bloomfield, Sandeep Ladha, Ian J. Fraser, John M. Ellard
Publikováno v:
Journal of medicinal chemistry. 65(9)
d-Serine is a coagonist of the
Autor:
Miguel Martin, Rocio Ramos-Medina, Rebeca Bernat, Jose Angel Garcia Saenz, Maria Del Monte-Millan, Enrique Alvarez, Maria Cebollero, Fernando Moreno, Eva Gonzalez Haba, Oscar Bueno, Paula Romero, Tatiana Massarrah, Isabel Echavarria, Yolanda Jerez, Blanca Herrero, Ricardo Gonzalez Del Val, Nerea Lobato, Patricia Rincon, Maria Isabel Palomero, Ivan Marquez-Rodas, Santiago Lizarraga, Fernando Asensio, Sara Lopez-Tarruella
Background: Triple-negative breast cancer (TNBC) is highly responsive to neoadjuvant polychemotherapy regimens including anthracyclines, taxanes, and, more recently, carboplatin. However, there is inadequate information on the individual contribution
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::11249e33d57a11a01beba9dd4cddb109
https://doi.org/10.21203/rs.3.rs-57678/v1
https://doi.org/10.21203/rs.3.rs-57678/v1
Autor:
Miles N. Tackett, John B. J. Pavey, Kieron E. Wesson, David Osborn, Maria A. Palomero, Masakuni Kori, Michael C. Willis, James S. Scott, Jag Paul Heer, Matthew L. Maddess, James C. Anderson, Hidenori Watanabe, Paul Brennan, Michael W. Cappi, Catherine Pinel, Joanne Norman, Céline Helgen, Jiirgen Schnaubelt, Stephen P. Marsden, Lesley A. Robinson, Christopher D. Spilling, Steven V. Ley, Cyrille Kouklovsky
For over 30 years, rapamycin has generated a sustained and intense interest from the scientific community as a result of its exceptional pharmacological properties and challenging structural features. In addition to its well known therapeutic value a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54706266323cc943ab83a92c095d5f77
https://ora.ox.ac.uk/objects/uuid:001f9546-a1be-4c4e-985b-5e92b3d0916f
https://ora.ox.ac.uk/objects/uuid:001f9546-a1be-4c4e-985b-5e92b3d0916f